These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells. Liu R; Mendez-Rios JD; Peng C; Xiao W; Weisberg AS; Wyatt LS; Moss B PLoS Pathog; 2019 May; 15(5):e1007710. PubMed ID: 31145755 [TBL] [Abstract][Full Text] [Related]
23. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. Wolffe EJ; Isaacs SN; Moss B J Virol; 1993 Aug; 67(8):4732-41. PubMed ID: 8331727 [TBL] [Abstract][Full Text] [Related]
24. Transient host range selection for genetic engineering of modified vaccinia virus Ankara. Staib C; Drexler I; Ohlmann M; Wintersperger S; Erfle V; Sutter G Biotechniques; 2000 Jun; 28(6):1137-42, 1144-6, 1148. PubMed ID: 10868279 [TBL] [Abstract][Full Text] [Related]
25. Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses. Baur K; Brinkmann K; Schweneker M; Pätzold J; Meisinger-Henschel C; Hermann J; Steigerwald R; Chaplin P; Suter M; Hausmann J J Virol; 2010 Sep; 84(17):8743-52. PubMed ID: 20538860 [TBL] [Abstract][Full Text] [Related]
26. Vaccinia virus morphogenesis is interrupted when expression of the gene encoding an 11-kilodalton phosphorylated protein is prevented by the Escherichia coli lac repressor. Zhang YF; Moss B J Virol; 1991 Nov; 65(11):6101-10. PubMed ID: 1920628 [TBL] [Abstract][Full Text] [Related]
27. Isolation of vaccinia MVA recombinants using the viral F13L gene as the selective marker. Sánchez-Puig JM; Blasco R Biotechniques; 2005 Nov; 39(5):665-6, 668, 670 passim. PubMed ID: 16312215 [TBL] [Abstract][Full Text] [Related]
28. [Expression of beta-galactosidase in recombinant nonintegrated plasmids in evaluating the functional activity of vaccinia virus promoters]. Loparev VN; Chernos VI Mol Gen Mikrobiol Virusol; 1987 Nov; (11):34-9. PubMed ID: 3127696 [TBL] [Abstract][Full Text] [Related]
29. Construction of chimeric vaccinia viruses by molecular cloning and packaging. Scheiflinger F; Dorner F; Falkner FG Proc Natl Acad Sci U S A; 1992 Nov; 89(21):9977-81. PubMed ID: 1438247 [TBL] [Abstract][Full Text] [Related]
30. Vectors for recombinational cloning and gene expression in mammalian cells using modified vaccinia virus Ankara. Pradeau-Aubreton K; Ruff M; Garnier JM; Schultz P; Drillien R Anal Biochem; 2010 Sep; 404(1):103-5. PubMed ID: 20450873 [TBL] [Abstract][Full Text] [Related]
31. [A novel double expression shuttle vector to get marker-free recombinant modified vaccinia virus Ankara]. Zheng Q; Bi Z; Li M; Hou J; Chen P Sheng Wu Gong Cheng Xue Bao; 2011 Jun; 27(6):926-34. PubMed ID: 22034822 [TBL] [Abstract][Full Text] [Related]
32. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. Meyer H; Sutter G; Mayr A J Gen Virol; 1991 May; 72 ( Pt 5)():1031-8. PubMed ID: 2033387 [TBL] [Abstract][Full Text] [Related]
33. Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice. Meisinger-Henschel C; Späth M; Lukassen S; Wolferstätter M; Kachelriess H; Baur K; Dirmeier U; Wagner M; Chaplin P; Suter M; Hausmann J J Virol; 2010 Oct; 84(19):9907-19. PubMed ID: 20668072 [TBL] [Abstract][Full Text] [Related]
35. Regulated expression of foreign genes in vaccinia virus under the control of bacteriophage T7 RNA polymerase and the Escherichia coli lac repressor. Alexander WA; Moss B; Fuerst TR J Virol; 1992 May; 66(5):2934-42. PubMed ID: 1560532 [TBL] [Abstract][Full Text] [Related]
36. Comparison of virus production in chicken embryo fibroblasts infected with the WR, IHD-J and MVA strains of vaccinia virus: IHD-J is most efficient in trans-Golgi network wrapping and extracellular enveloped virus release. Meiser A; Boulanger D; Sutter G; Krijnse Locker J J Gen Virol; 2003 Jun; 84(Pt 6):1383-1392. PubMed ID: 12771405 [TBL] [Abstract][Full Text] [Related]
37. Activity of a fowlpox virus late gene promoter in vaccinia and fowlpox virus recombinants. Kumar S; Boyle DB Arch Virol; 1990; 112(3-4):139-48. PubMed ID: 2165765 [TBL] [Abstract][Full Text] [Related]
38. Extrachromosomal recombination in vaccinia-infected cells requires a functional DNA polymerase participating at a level other than DNA replication. Colinas RJ; Condit RC; Paoletti E Virus Res; 1990 Dec; 18(1):49-70. PubMed ID: 2127968 [TBL] [Abstract][Full Text] [Related]
39. Transient marker stabilisation: a general procedure to construct marker-free recombinant vaccinia virus. Scheiflinger F; Dorner F; Falkner FG Arch Virol; 1998; 143(3):467-74. PubMed ID: 9572548 [TBL] [Abstract][Full Text] [Related]
40. The 5' noncoding region sequence of the Choristoneura biennis entomopoxvirus spheroidin gene functions as an efficient late promoter in the mammalian vaccinia expression system. Pearson A; Richardson C; Yuen L Virology; 1991 Feb; 180(2):561-6. PubMed ID: 1899170 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]